Digital Pathology Market Trends, Share, Opportunities and Forecast By 2029
The realistic Digital Pathology market survey report contains thorough description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis and porter's five force analysis. The market is considerably transforming because of the moves of the key players and brands including developments, product launches, joint ventures, mergers and acquisitions that in turn changes the view of the global face of Healthcare industry. By keeping end users at the centre point, a team of researchers, forecasters, analysts and industry experts work painstakingly to create Digital Pathology market research document.
Data Bridge Market Research analyses that the digital pathology market which was USD 971.49 million in 2021, is expected to reach USD 2,492.64 million by 2029, at a CAGR of 12.5% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-digital-pathology-market
Market Overview:
Digital pathology is the practise of pathology that employs digital imaging. Digital pathology is the use of computer workstations to view digital whole slide images (WSIs) obtained from high resolution scanning of glass microscope slides applications include teaching, research and primary diagnostic reporting.
COVID-19 Impact on the Digital Pathology Market
The COVID-19 pandemic had a significant impact on digital pathology services. Digital pathology has the potential to "protect clinical services and pathology-based research in the current and future climates. This digital-based diagnostic approach represents a new approach to evaluating surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It liberates the pathologist from the constraints of working with an optical microscope in his or her office. At the same time, it can have an impact on pathologists “social interaction,' including their interactions with clinicians and even patients. At the peak of the COVID-19 pandemic, a recent contribution from our group briefly addressed the changing aspects of such a relationship.
Recent developments
On September 2, 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm's portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent's portfolio of automated pathology staining solutions. Based on a shared vision of end-to-end quality and standardisation of tissue diagnostics, the alliance will address the unmet needs of pathology laboratories around the world. The companies' shared goal is to create technology, products, and services that will improve pathology lab uniformity and speed up correct diagnosis.
In April 2021, OptraSCAN will introduced OS-Ultra 320 high-speed scanners. The device is designed to scan cells/tissues 15x15 mm in size at 40x magnification in 60 seconds. Furthermore, the widespread use of scanners in pathology labs is propelling market growth.
Competitive Landscape and Digital Pathology Market Share Analysis
The digital pathology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital pathology market.
Some of the major players operating in the digital pathology market are:
-
F. Hoffmann-La Roche Ltd (Switzerland)
-
Hamamatsu Photonics (Japan)
-
3DHISTECH Ltd. (Hungary)
-
AstraZeneca (U.K.)
-
General Electric (U.S.)
-
Healthcare Trading Co. LLC (UAE)
-
Koninklijke Philips N.V (Netherlands)
-
Inspirata, Inc. (U.S.)
-
Olympus Corporation (Japan)
-
Sectra AB (U.S.), PerkinElmer Inc. (U.S.)
-
Apollo Enterprise Imaging Corp (U.S.)
-
Mikroscan Technologies, Inc. (U.S.)
-
VMscope GmbH (Germany)
-
Huron Technologies International Inc. (Canada)
-
Objective Pathology Services Limited (Canada)
Browse Trending Reports:
https://www.databridgemarketresearch.com/reports/global-medical-personal-protective-equipment-market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian